Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children
Oshitani, H.; Suzuki, H.; Mpabalwani, M.E.; Mizuta, K.; Numazaki, Y.
Lancet 348(9024): 415
1996
ISSN/ISBN: 0140-6736 PMID: 8709770 DOI: 10.1016/s0140-6736(05)65044-1Document Number: 299411
Document emailed within 0-6 h
Related Documents
Nair, N.; Moss, W.J.; Scott, S.; Mugala, N.; Ndhlovu, Z.M.; Lilo, K.; Ryon, J.J.; Monze, M.; Quinn, T.C.; Cousens, S.; Cutts, F.; Griffin, D.E. 2009: HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection Journal of Infectious Diseases 200(7): 1031-1038Arambepola, R.; Yang, Y.; Hutchinson, K.; Mwansa, F.D.; Doherty, J.A.; Bwalya, F.; Ndubani, P.; Musukwa, G.; Moss, W.J.; Wesolowski, A.; Mutembo, S. 2021: Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia Bmj Global Health 6(12)
Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
Rainwater-Lovett, K.; Nkamba, H.C.; Mubiana-Mbewe, M.; Bolton-Moore, C.; Moss, W.J. 2013: Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities Journal of Infectious Diseases 208(11): 1747-1755
Benn, C.S.; Martins, Cário.L.; Andersen, A.; Fisker, A.B.; Whittle, H.C.; Aaby, P. 2020: Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival Frontiers in Pediatrics 8: 20
Rosales, F.J. 2002: Vitamin a supplementation of vitamin a deficient measles patients lowers the risk of measles-related pneumonia in zambian children Journal of Nutrition 132(12): 3700-3703
Techasena, W.; Wongwacharapiboon, P.; Terawanich, S.; Pattamadilok, S. 2011: A comparison study of measles antibody between two doses vaccination at 9, 18 months and single dose at 9 months in children 4-6 years old Journal of the Medical Association of Thailand 94(3): 309-315
Murhekar, M.V.; Ahmad, M.; Shukla, H.; Abhishek, K.; Perry, R.T.; Bose, A.S.; Shimpi, R.; Kumar, A.; Kaliaperumal, K.; Sethi, R.; Selvaraj, V.; Kamaraj, P.; Routray, S.; Das, V.Nand.; Menabde, N.; Bahl, S. 2014: Measles case fatality rate in Bihar, India, 2011-12 Plos one 9(5): E96668
Sudfeld, C.R.; Halsey, N.A. 2009: Measles case fatality ratio in India a review of community based studies Indian Pediatrics 46(11): 983-989
Moss, W.J.; Ryon, J.J.; Monze, M.; Griffin, D.E. 2002: Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children Journal of Infectious Diseases 186(7): 879-887
Fathy, M.M.; el-Khashaab, T.H.; Darwish, M.A. 1992: Antibody level after measles vaccination Journal of the Egyptian Public Health Association 67(3-4): 369-378
Ryon, J.J.; Moss, W.J.; Monze, M.; Quinn, T.C.; Griffin, D.E. 2005: Influence of HIV infection on changes in circulating leukocyte counts during measles in Zambian children Journal of Infectious Diseases 192(11): 1950-1955
Schmöger, R.; Becker, H.; Enders-Ruckle, G. 1971: Combination vaccination in children's homes with regard to measles vaccination Medizinische Klinik 66(6): 194-198
Moss, W.J.; Fisher, C.; Scott, S.; Monze, M.; Ryon, J.J.; Quinn, T.C.; Griffin, D.E.; Cutts, F.T. 2008: HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 46(4): 523-527
Kuwajima, S. 1986: Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines Hokkaido Journal of Medical Science 61(1): 5-14
Dutta, A.K.; Singhal, P.K.; Khare, S.; Kumari, S.; Mathur, R.; Mullick, D.N. 1989: Immune status following measles vaccination in infants and evaluation for the need of revaccination Indian Pediatrics 26(8): 765-772
Babakura, B.; Nomhwange, T.; Jean Baptiste, A.E.; Dede, O.; Taiwo, L.; Abba, S.; Soyemi, M.; Idowu, A.M.; Terna Richard, M.; Braka, F.; Oteri, J.; Shuaib, F. 2021: The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: a case study of 2017/18 measles campaign in Borno state, Nigeria Vaccine 39(Suppl 3): C66-C75
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157
John, T.J. 2008: Death of children after measles vaccination Indian Pediatrics 45(6): 477-478
Naruszewicz-Lesiuk, D.; Kańtoch, M.; Polna, I. 1974: Immunologic response and post-vaccination reactions in children vaccinated against measles. I. Assessment of post-vaccination reactions Przeglad Epidemiologiczny 28(3): 315-324